LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_177438.3:c.2367_2369delinsCTGATATCCTCCT
DICER1
· NP_803187.1:p.(Arg789SerfsTer2)
· NM_177438.3
GRCh37: chr14:95574728 CGC>AGGAGGATATCAG
·
GRCh38: chr14:95108391 CGC>AGGAGGATATCAG
Gene:
DICER1
Transcript:
NM_177438.3
Final call
Likely Pathogenic
PVS1 very strong
Variant details
Gene
DICER1
Transcript
NM_177438.3
Protein
NP_803187.1:p.(Arg789SerfsTer2)
gnomAD AF
ClinVar
OncoKB
Likely Oncogenic
Classification rationale
Interpretation summary
Generated evidence synthesis
1
Likely Pathogenic: PVS1 (very strong) is met because the exon 15 frameshift creates p.Arg789SerfsTer2 before the DICER1 NMD cutoff.
Final determination:
Under the DICER1 VCEP Version 1.4 point-based framework, a total score of 8 points maps to Likely Pathogenic.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | Met | Met, very strong: frameshift p.Arg789SerfsTer2 creates a stop at p.790, 5' of the DICER1 NMD cutoff at p.Pro1850. |
cspec
vcep_pvs1_decisiontree
pvs1_variant_assessment
|
| PS1 | N/A | Not applicable: the variant is a frameshift, whereas PS1 requires comparison of the same amino-acid change. |
cspec
|
| PS2 | Not assessed | Not assessed: no documented parental testing, de novo observation, or de novo point total is available to apply the VCEP PS2 thresholds. |
cspec
|
| PS3 | Not assessed | Not assessed: No variant-specific RNA or pre-miRNA cleavage assay with the VCEP-required controls was reported for c.2367_2369delinsCTGATATCCTCCT. |
cspec
PMID:20305640
PMID:21266384
PMID:21501861
PMID:22353998
|
| PS4 | Not assessed | Not assessed: no exact-variant phenotype points, case-control counts, odds ratio, confidence interval, or qualifying rare-variant case series were available. |
cspec
PMID:20305640
PMID:21266384
PMID:21501861
PMID:22353998
|
| PM1 | N/A | Not applicable: the variant is p.Arg789SerfsTer2, not a putative missense variant in the VCEP-defined metal-binding residues or RNase IIIb domain. |
cspec
|
| PM2 | Not assessed | Not assessed: gnomAD reports absence, but the required ≤1 allele per subpopulation and ≥20x coverage data are unavailable. |
cspec
gnomad_v2
gnomad_v4
|
| PM3 | N/A | Not applicable: the DICER1 VCEP specifies autosomal dominant inheritance, so PM3's recessive in-trans criterion does not apply. |
cspec
|
| PM4 | N/A | Not applicable: the variant is a frameshift, whereas DICER1 PM4 is restricted to in-frame indels. |
cspec
pvs1_variant_assessment
|
| PM5 | N/A | Not applicable: PM5 requires a missense variant under evaluation, but this variant is a frameshift ending two residues after Arg789. |
cspec
|
| PM6 | N/A | Not applicable: the VCEP explicitly directs users to combine de novo evidence with PS2 and use PS2 instead of PM6. |
cspec
|
| PP1 | Not assessed | Not assessed: no affected relatives, genotype segregation results, or meiosis count are documented for comparison with the VCEP PP1 thresholds. |
cspec
|
| PP2 | N/A | Not applicable: the DICER1 VCEP explicitly recommends not using PP2 because benign and likely benign missense variants occur throughout the gene. |
cspec
|
| PP3 | N/A | Not applicable: the variant is an exon 15 frameshift, whereas PP3 names only missense or splicing variants for computational prediction evidence. |
cspec
pvs1_variant_assessment
|
| PP4 | Not assessed | Not assessed: no tumor sequencing evidence showed a qualifying RNase IIIb hotspot second hit, germline retention, and absence of additional somatic loss-of-function variants. |
cspec
|
| PP5 | N/A | Not applicable: the DICER1 VCEP explicitly prohibits use of PP5. |
cspec
|
| BA1 | Not assessed | Not assessed: gnomAD reports absence, but required subpopulation denominators (>2,000 alleles) and allele counts are unavailable. |
cspec
gnomad_v2
gnomad_v4
|
| BS1 | Not assessed | Not assessed: gnomAD reports absence, but required subpopulation denominators (>2,000 alleles) and allele counts are unavailable. |
cspec
gnomad_v2
gnomad_v4
|
| BS2 | Not assessed | Not assessed: gnomAD reports absence, but no qualifying healthy individuals, homozygotes, parental confirmation, or tumor-free female cohort is documented. |
cspec
gnomad_v2
gnomad_v4
|
| BS3 | Not assessed | Not assessed: No controlled assay demonstrated normal splicing or production of both 5p and 3p microRNAs for this variant. |
cspec
PMID:20305640
PMID:21266384
PMID:21501861
PMID:22353998
|
| BS4 | Not assessed | Not assessed: no phenotype-positive, genotype-negative first-, second-, or third-degree relatives are documented for the VCEP BS4 rule. |
cspec
|
| BP1 | N/A | Not applicable: the VCEP explicitly excludes BP1 for DICER1 because truncating variants account for only a portion of disease-causing variants. |
cspec
|
| BP2 | Not assessed | Not assessed: no proband observation, P/LP DICER1 partner variant, or trans/cis/phase-unknown evidence is available to evaluate the VCEP threshold. |
cspec
|
| BP3 | N/A | Not applicable: the DICER1 VCEP explicitly designates BP3 as not applicable, and this variant is a coding frameshift. |
cspec
pvs1_variant_assessment
|
| BP4 | N/A | Not applicable: BP4 names missense, synonymous, intronic, and non-coding variants, but this variant is an exonic frameshift in exon 15. |
cspec
pvs1_variant_assessment
|
| BP5 | N/A | Not applicable: the DICER1 VCEP explicitly says BP5 should not be used for this gene. |
cspec
|
| BP6 | N/A | Not applicable: the DICER1 VCEP explicitly prohibits use of BP6. |
cspec
|
| BP7 | N/A | Not applicable: BP7 covers silent, intronic, or other non-coding variants, whereas this variant is an exonic frameshift in exon 15. |
cspec
pvs1_variant_assessment
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.